MLL-AF4 Spreading Identifies Binding Sites that Are Distinct from Super-Enhancers and that Govern Sensitivity to DOT1L Inhibition in Leukemia.

MLL-AF4 Spreading Identifies Binding Sites that Are Distinct from Super-Enhancers and that Govern Sensitivity to DOT1L Inhibition in Leukemia.

Understanding the underlying molecular mechanisms of defined cancers is crucial for effective personalized therapies. Translocations of the mixed-lineage leukemia (MLL) gene produce fusion proteins such as MLL-AF4 that disrupt epigenetic pathways and cause poor-prognosis leukemias. Here, we find tha...

書目詳細資料
Main Authors:	Kerry, J, Godfrey, L, Repapi, E, Tapia, M, Blackledge, N, Ma, H, Ballabio, E, O'Byrne, S, Ponthan, F, Heidenreich, O, Roy, A, Roberts, I, Konopleva, M, Klose, R, Geng, H, Milne, T
格式:	Journal article
語言:	English
出版:	Cell Press 2017

相似書籍

MLL-AF4 Spreading Identifies Binding Sites that Are Distinct from Super-Enhancers and that Govern Sensitivity to DOT1L Inhibition in Leukemia
由: Jon Kerry, et al.
出版: (2017-01-01)

MLL-AF4 binds directly to a BCL-2 specific enhancer and modulates H3K27 acetylation.
由: Godfrey, L, et al.
出版: (2016)

The role of DOT1L in MLL-AF4 leukaemia
由: Godfrey, L
出版: (2018)

Molecular and Epigenetic Mechanisms of MLL in Human Leukemogenesis.
由: Ballabio, E, et al.
出版: (2012)

P314: THERAPEUTICALLY TARGETING THE UNIQUE BARCODE OF MLL/AF4
由: R. Cameron, et al.
出版: (2022-06-01)

RUNX1 is a key target in t(4;11) leukemias that contributes to gene activation through an AF4-MLL complex interaction.
由: Wilkinson, A, et al.
出版: (2013)

RUNX1 Is a Key Target in t(4;11) Leukemias that Contributes to Gene Activation through an AF4-MLL Complex Interaction
由: Wilkinson, A, et al.
出版: (2013)

Next generation sequencing techniques reveal molecular mechanisms of MYB regulation and function in MLL-AF9 Leukemia
由: Lau, I, et al.
出版: (2017)

The basic helix-loop-helix transcription factor SHARP1 is an oncogenic driver in MLL-AF6 acute myelogenous leukemia
由: Numata, A, et al.
出版: (2018)

The function of PRC2 in MLL-AF4 acute lymphoid leukaemia
由: Tapia, M
出版: (2015)

Aggressive leukemia driven by MLL-AF9
由: Vaia Stavropoulou, et al.
出版: (2018-05-01)

RUNX1 Is a Key Target in t(4;11) Leukemias that Contributes to Gene Activation through an AF4-MLL Complex Interaction
由: Adam C. Wilkinson, et al.
出版: (2013-01-01)

PAF1 and FACT cooperate with MLL-AF4 to drive enhancer activity in leukemia
由: Milne, T, et al.
出版: (2022)

The basic helix-loop-helix transcription factor SHARP1 is an oncogenic driver in MLL-AF6 acute myelogenous leukemia
由: Akihiko Numata, et al.
出版: (2018-04-01)

The role of MYB in MLL-AF9 leukaemia
由: Lau, IJ
出版: (2019)

H3K79me2/3 controls enhancer–promoter interactions and activation of the pan-cancer stem cell marker PROM1/CD133 in MLL-AF4 leukemia cells
由: Godfrey, L, et al.
出版: (2020)

Enhanced hemato-endothelial specification during human embryonic differentiation through developmental cooperation between AF4-MLL and MLL-AF4 fusions
由: Clara Bueno, et al.
出版: (2019-06-01)

MLL-AF4 cooperates with PAF1 and FACT to drive high-density enhancer interactions in leukemia
由: Crump, NT, et al.
出版: (2023)

MLL-AF4 cooperates with PAF1 and FACT to drive high-density enhancer interactions in leukemia
由: Nicholas T. Crump, et al.
出版: (2023-08-01)

A human fetal liver-derived infant MLL-AF4 acute lymphoblastic leukemia model reveals a distinct fetal gene expression program
由: Rice, S, et al.
出版: (2021)

Simultaneous localization of MLL, AF4 and ENL genes in interphase nuclei by 3D-FISH: MLL translocation revisited
由: Sun Jian-Sheng, et al.
出版: (2006-01-01)

Neonatal acute lymphoblastic leukemia (MLL-AF9) with leukemia cutis
由: Yu-Tsung Yin, et al.
出版: (2021-11-01)

MLL-AF9 initiates transformation from fast-proliferating myeloid progenitors
由: Xinyue Chen, et al.
出版: (2019-12-01)

A human fetal liver-derived infant MLL-AF4 acute lymphoblastic leukemia model reveals a distinct fetal gene expression program
由: Siobhan Rice, et al.
出版: (2021-11-01)

Protocol to establish a stable MLL-AF9_AML mouse model
由: Jun Lu, et al.
出版: (2022-09-01)

The MLL family of proteins in normal development and disease
由: Milne, TA
出版: (2020)

Inter-chromosomal recombination of Mll and Af9 genes mediated by cre-loxP in mouse development.
由: Collins, E, et al.
出版: (2000)

Publisher Correction: MLL-AF9 initiates transformation from fast-proliferating myeloid progenitors
由: Xinyue Chen, et al.
出版: (2020-01-01)

Degree of Recruitment of DOT1L to MLL-AF9 Defines Level of H3K79 Di- and Tri-methylation on Target Genes and Transformation Potential
由: Aravinda Kuntimaddi, et al.
出版: (2015-05-01)

MLL-AF9 leukemias are sensitive to PARP1 inhibitors combined with cytotoxic drugs
由: Silvia Maifrede, et al.
出版: (2017-08-01)

Zoledronic acid inhibits the growth of leukemic MLL-AF9 transformed hematopoietic cells
由: Emanuela Chiarella, et al.
出版: (2020-06-01)

DOT1L inhibition sensitizes MLL-rearranged AML to chemotherapy.
由: Wei Liu, et al.
出版: (2014-01-01)

Mouse Af9 is a controller of embryo patterning, like Mll, whose human homologue fuses with Af9 after chromosomal translocation in leukemia.
由: Collins, E, et al.
出版: (2002)

A conditional model of MLL-AF4 B-cell tumourigenesis using invertor technology.
由: Metzler, M, et al.
出版: (2006)

Isolated meningeal myeloid sarcoma with recurrent MLL-AF6 translocation: a case report
由: Chunyan Wang, et al.
出版: (2023-03-01)

HBO1-MLL interaction promotes AF4/ENL/P-TEFb-mediated leukemogenesis
由: Satoshi Takahashi, et al.
出版: (2021-08-01)

MLL-AF4 fusion transcripts in Acute Lymphocytic Leukemia patientsin Children hospital of Tabriz
由: Amir Monfaredan, et al.
出版: (2014-08-01)

BET inhibition disrupts transcription but retains enhancer-promoter contact
由: Nicholas Crump, et al.
出版: (2019)

MLL5 expression as a biomarker for DNA hypermethylation and sensitivity to epigenetic therapy.
由: Milne, T
出版: (2014)

The human leukemic oncogene MLL-AF4 promotes hyperplastic growth of hematopoietic tissues in Drosophila larvae
由: Julie A. Johannessen, et al.
出版: (2023-10-01)